MELISSA DENNEY: Open Payments
NPI 1588147755 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 65 payments from 17 companies in 2025. Trend: 2023 $733 · 2024 $745 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $479 |
| Indivior Inc. | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Novo Nordisk Inc | 4 | $66 |
| Verona Pharma, Inc. | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Amgen Inc. | 2 | $30 |
| Insulet Corporation | 1 | $24 |
Products named: VRAYLAR, MAVYRET, SUBLOCADE, Kerendia, CAPLYTA, UBRELVY, QULIPTA, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
